Javelin Pharmaceuticals' EBITDA Hits Two Year High
Stock Quote:(N/A:JAV)
11/19/2009
0.00
N/A
N/A
0
Javelin Pharmaceuticals' EBITDA Hits Two Year High
Last
Price Change
% Chg
Volume
New York, NY, November 19, 2009-Ebitda News reports that negative EBITDA for Javelin Pharmaceuticals, Inc. (AMEX:JAV) for its quarter ended September 30, 2009 was $(6,138,447), a 44% improvement over ... read full story
Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story
N/A 
